ROS1 and lung cancer: SLC34A2, a pH-sensitive sodium-dependent phosphate transporter (52), is associated with lung cancer (53), and the SLC34A2-ROS1 fusion gene can induce crizotinib resistance and enhance carcinogenicity (54, 55).